Co-Diagnostics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount
Co-Diagnostics, Inc. (CODX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount of -$6.10 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation · last filed 2020-03-30
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, depreciation, amount for fiscal 2019 was -$6.10K.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, depreciation, amount for fiscal 2018 was -$3.00K, a 161.22% decline from fiscal 2017.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, nondeductible expense, depreciation, amount for fiscal 2017 was $4.90K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount 12 month |
|---|---|
| 2019-12-31 | -$6.10K 10-K · filed 2020-03-30 |
| 2018-12-31 | -$3.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $4.90K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |